Alfuzosin hydrochloride
Cat. No.:YN321414
产品名称: | Alfuzosin hydrochloride |
CAS No.: | 81403-68-1 |
Chemical Name: | N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide, monohydrochloride |
Synonyms: | 盐酸阿夫唑嗪; SL 77499-10 |
分子量: | 425.91 |
分子式: | C₁₉H₂₈ClN₅O₄ |
SMILES: | O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Alfuzosin盐酸盐是α1肾上腺素受体拮抗剂,可作用于良性前列腺增生(BPH)。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Sinclair, A.J., Davies, I.B., and Warrington, S.J.Alfuzosin and the venous reflex response: Studies in normal subjectsBr. J. Clin. Pharmacol.27,19-22(1989)
Jardin, A., Bensadoun, H., Delauche-Cavallier, M.C., et al.Alfuzosin for treatment of benign prostatic hypertrophyLancet337,1457-1461(1991)
Kenny, B.A., Miller, A.M., Williamson, I.J.R., et al.Evaluation of the pharmacological selectivity profile of α1 adrenoceptor antagonists at prostatic α1 adrenoceptors: Binding, functional and in vivo studiesBr. J. Pharmacol.118(4),871-878(1996)
Roehrborn, C.G., and Rosen, R.C.Medical therapy options for aging men with benign prostatic hyperplasia: Focus on alfuzosin 10 mg once dailyClin. Interv. Aging3(3),511-524(2008)
Nickel, J.C., Sander, S., and Moon, T.D.A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasiaInt. J. Clin. Pract.62(10),1547-1559(2008)
Michel, M.C.The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: α-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?J. Pharmacol. Sci.112,151-157(2010)